Park Medi World Ltd
As of 16 Oct 2026, Park Medi World is in Stage 3 — topping, where an uptrend loses steam, in week 2 (since 8 Oct 2026). It closed at ₹236, below its 200-day average. In Health Care, 40.6% of stocks are in Stage 2.
Park Medi World Limited operates a network of hospitals. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is PARKHOSPS early, or has it already run? Pro answers that for every NSE stock, after every close.
About this companyHealth Care· Hospitals & Diagnostic Centres
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumatology, ENT, ophthalmology, obstetrics and gynaecology, interventional radiology and imaging, psychiatry, pathology and microbiology, paediatric surgery, fertility management, nuclear medicine services. It operates NABH accredited multi-super specialty hospitals under the Park brand name. Park Medi World Limited was founded in 2005 and is headquartered in Gurugram, India.
Visit company website →All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.